ARTICLE | Company News
Asuragen, Becton Dickinson deal
June 25, 2012 7:00 AM UTC
Asuragen granted Becton Dickinson non-exclusive, worldwide rights to Asuragen's Armored RNA technology for use in in vitro diagnostic products. Asuragen will develop and supply reagents for Becton Dic...